mianserin has been researched along with Psychoses, Drug in 4 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamadjida, A | 1 |
| Nuara, SG | 1 |
| Veyres, N | 1 |
| Frouni, I | 1 |
| Kwan, C | 1 |
| Sid-Otmane, L | 1 |
| Harraka, MJ | 1 |
| Gourdon, JC | 1 |
| Huot, P | 1 |
| Ikeguchi, K | 2 |
| Kuroda, A | 2 |
| Friedman, JH | 1 |
| Normann, C | 1 |
| Hesslinger, B | 1 |
| Frauenknecht, S | 1 |
| Berger, M | 1 |
| Walden, J | 1 |
4 other studies available for mianserin and Psychoses, Drug
| Article | Year |
|---|---|
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyski | 2017 |
Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Dru | 1995 |
Comments and reply on Ikeguchi and Kuroda: Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Humans; Mianserin; Parkinson Disease | 1996 |
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interaction | 1997 |